Takayuki Mori Selected Research

Tolvaptan

1/2021

[Retrospective Observational Study on Predictors of Body Weight and BNP Teduction in Cases of Tolvaptan Induction for Heart Failure].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takayuki Mori Research Topics

Disease

5	Prostatic Neoplasms (Prostate Cancer) 08/2023 - 01/2023
5	Inflammation (Inflammations) 01/2017 - 01/2012
4	Carcinogenesis 01/2017 - 01/2012
3	Lower Urinary Tract Symptoms 08/2023 - 01/2023
3	Neoplasms (Cancer) 06/2021 - 08/2014
3	Heart Failure 01/2021 - 01/2020
3	Adenocarcinoma 02/2016 - 01/2012
2	Hemorrhage 07/2023 - 01/2019
2	Ischemia 01/2020 - 05/2017
2	Drug-Related Side Effects and Adverse Reactions 01/2019 - 01/2018
2	Colitis 08/2014 - 01/2012
2	Neoplasm Metastasis (Metastasis) 11/2013 - 11/2013
1	Central Nervous System Diseases (CNS Diseases) 04/2024
1	Overactive Urinary Bladder (Overactive Bladder) 07/2023
1	AIDS-Related Complex (ARC) 03/2023
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2023
1	Cerebral Hemorrhage 12/2022
1	Out-of-Hospital Cardiac Arrest 12/2022
1	Tachycardia (Tachyarrhythmias) 12/2022
1	Endometrial Neoplasms (Endometrial Cancer) 06/2022
1	Ascites 06/2022
1	Disease Progression 01/2022
1	Myasthenia Gravis 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Stable Angina 01/2021
1	Death (Near-Death Experience) 01/2021
1	Pseudohypoaldosteronism 11/2020
1	Thrombosis (Thrombus) 01/2020
1	Stroke (Strokes) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Unstable Angina 01/2020
1	Communicable Diseases (Infectious Diseases) 03/2019
1	Infertility (Sterility) 02/2019
1	Illusions (Auditory Illusions) 01/2019
1	Ototoxicity 01/2018
1	Left Ventricular Dysfunction 05/2017
1	Pathologic Constriction (Stenosis) 05/2017
1	Nervous System Diseases (Neurological Disorders) 06/2016
1	Hearing Loss (Hearing Impairment) 06/2016
1	Encephalitis (Encephalitis, Rasmussen) 06/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2016

Drug/Important Bio-Agent (IBA)

3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 02/2016 - 01/2012
3	Dextrans (Dextran)FDA Link 02/2016 - 01/2012
3	AzoxymethaneIBA 02/2016 - 01/2012
3	CytokinesIBA 08/2014 - 01/2012
2	AntibodiesIBA 04/2024 - 08/2004
2	CalciumIBA 07/2023 - 03/2023
2	Iodine-125IBA 01/2023 - 01/2023
2	omega-Chloroacetophenone (Mace)IBA 01/2020 - 05/2017
2	clobenpropitIBA 01/2017 - 02/2016
2	Cimetidine (Biomet)FDA LinkGeneric 01/2017 - 02/2016
2	EnzymesIBA 08/2014 - 01/2012
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2014 - 01/2012
2	Messenger RNA (mRNA)IBA 07/2014 - 01/2012
2	NitratesIBA 01/2004 - 12/2002
2	NitritesIBA 01/2004 - 12/2002
1	Small Interfering RNA (siRNA)IBA 01/2023
1	Lipocalin-2IBA 01/2023
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2023
1	metabotropic glutamate receptor 3 (mGluR3)IBA 01/2023
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2023
1	GadoliniumIBA 06/2022
1	Lipoprotein Receptors (Lipoprotein Receptor)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	fibrin fragment D (D-dimer)IBA 06/2021
1	Tolvaptan FDA Link 01/2021
1	SodiumIBA 01/2021
1	Furosemide (Lasix)FDA LinkGeneric 01/2021
1	Cullin Proteins (Cullins)IBA 11/2020
1	Peptides (Polypeptides)IBA 02/2019
1	apixabanIBA 01/2019
1	edoxabanIBA 01/2019
1	AnticoagulantsIBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	RivaroxabanIBA 01/2019
1	Dabigatran FDA Link 01/2019
1	Platinum Compounds (Compounds, Platinum)IBA 01/2018
1	PlatinumIBA 01/2018
1	Histamine (Histamine Dihydrochloride)FDA Link 02/2016
1	Histamine Receptors (Histamine Receptor)IBA 02/2016
1	Drinking WaterIBA 02/2016
1	Terfenadine (Seldane)IBA 02/2016
1	SonazoidIBA 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2014
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 08/2014
1	4'-geranyloxyferulic acidIBA 08/2014
1	CyclodextrinsIBA 08/2014
1	4'-geranyloxyferulic acid-N(omega)-nitroarginine methyl esterIBA 08/2014

Therapy/Procedure

5	Brachytherapy 08/2023 - 01/2023
2	Percutaneous Coronary Intervention 07/2023 - 05/2017
2	Stents 01/2021 - 01/2020
2	Transcranial Direct Current Stimulation 01/2019 - 06/2016
2	Radiotherapy 01/2016 - 11/2013
1	Therapeutics 07/2023
1	Prostatectomy (Retropubic Prostatectomy) 01/2023
1	Aftercare (After-Treatment) 01/2023
1	Resuscitation 12/2022
1	Hysterectomy 06/2022
1	Drug Therapy (Chemotherapy) 03/2019
1	Contraindications 05/2017